These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36196507)

  • 1. Five-year surveillance study of clinical and environmental Triazole-Resistant Aspergillus fumigatus isolates in Iran.
    Khojasteh S; Abastabar M; Haghani I; Valadan R; Ghazanfari S; Abbasi K; Ahangarkani F; Zarrinfar H; Khodavaisy S; Badali H
    Mycoses; 2023 Feb; 66(2):98-105. PubMed ID: 36196507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species Distribution and Antifungal Susceptibilities of
    Badali H; Cañete-Gibas C; McCarthy D; Patterson H; Sanders C; David MP; Mele J; Fan H; Wiederhold NP
    J Clin Microbiol; 2022 May; 60(5):e0028022. PubMed ID: 35400175
    [No Abstract]   [Full Text] [Related]  

  • 4. Electronic equipment and appliances in special wards of hospitals as a source of azole-resistant Aspergillus fumigatus: a multi-centre study from Iran.
    Ghazanfari M; Abastabar M; Haghani I; Kermani F; Keikha N; Kholoujini M; Minooeianhaghighi MH; Jeddi SA; Shokri A; Ghojoghi A; Amirizad K; Azish M; Nasirzadeh Y; Roohi B; Nosratabadi M; Hedayati S; Ghanbari S; Valadan R; Hedayati MT
    J Hosp Infect; 2024 Mar; 145():65-76. PubMed ID: 38199436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned?
    Vaezi A; Fakhim H; Javidnia J; Khodavaisy S; Abtahian Z; Vojoodi M; Nourbakhsh F; Badali H
    J Mycol Med; 2018 Mar; 28(1):59-64. PubMed ID: 29496370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazole resistance in
    M Jimenez Madrid A; Paul RA; Rotondo F; Deblais L; Rajashekara G; Miller SA; Ivey MLL
    Appl Environ Microbiol; 2024 Apr; 90(4):e0001724. PubMed ID: 38534143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant
    Dellière S; Verdurme L; Bigot J; Dannaoui E; Senghor Y; Botterel F; Fekkar A; Bougnoux ME; Hennequin C; Guitard J
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extensive Genetic Diversity and Widespread Azole Resistance in Greenhouse Populations of Aspergillus fumigatus in Yunnan, China.
    Zhou D; Korfanty GA; Mo M; Wang R; Li X; Li H; Li S; Wu JY; Zhang KQ; Zhang Y; Xu J
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33568450
    [No Abstract]   [Full Text] [Related]  

  • 9. Surveillance for azole resistance in clinical and environmental isolates of Aspergillus fumigatus in Australia and cyp51A homology modelling of azole-resistant isolates.
    Talbot JJ; Subedi S; Halliday CL; Hibbs DE; Lai F; Lopez-Ruiz FJ; Harper L; Park RF; Cuddy WS; Biswas C; Cooley L; Carter D; Sorrell TC; Barrs VR; Chen SC
    J Antimicrob Chemother; 2018 Sep; 73(9):2347-2351. PubMed ID: 29846581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First azole-resistant Aspergillus fumigatus isolates with the environmental TR
    Ahangarkani F; Puts Y; Nabili M; Khodavaisy S; Moazeni M; Salehi Z; Laal Kargar M; Badali H; Meis JF
    Mycoses; 2020 May; 63(5):430-436. PubMed ID: 32056319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
    Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
    J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
    Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
    Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the activity of mold-active azole agents against
    Pfaller MA; Carvalhaes CG; Rhomberg PR; Desphande LM; Castanheira M
    J Clin Microbiol; 2024 Feb; 62(2):e0114123. PubMed ID: 38193696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazole resistance in Aspergillus fumigatus isolates in Africa: a systematic review.
    Amona FM; Oladele RO; Resendiz-Sharpe A; Denning DW; Kosmidis C; Lagrou K; Zhong H; Han L
    Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35906879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenotypic and Genotypic Evaluation of Azole Resistance in Aspergillus fumigatus Isolates from Clinical and Environmental Specimens].
    Doğan Ö; Gülmez D; Arıkan Akdağlı S
    Mikrobiyol Bul; 2020 Apr; 54(2):291-305. PubMed ID: 32723284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
    Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
    PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.